Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02591407
Other study ID # HSR 15-1618
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 2016
Est. completion date October 2018

Study information

Verified date May 2017
Source Saint Joseph Mercy Health System
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary outcome for this study is the Numeric Pain Score (NPS) for elective patients undergoing elective colorectal surgery that have been randomized to transversus abdominis plane block or epidural anesthesia for the management of perioperative pain in elective colorectal surgery.


Description:

Adequate peri-operative analgesia is a vital component of post-operative management for patients undergoing colon and rectal surgery, affecting hospital length of stay, quality of life, and patient outcomes. There are many options for the peri-operative management of pain after elective colorectal surgery.

This is a randomized clinical trial comparing the transversus abdominis plane block using Exparel® to epidural anesthesia for the enhanced recovery pathway perioperative management of pain for elective colorectal surgery.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 185
Est. completion date October 2018
Est. primary completion date July 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing elective open and minimally invasive (laparoscopic and robotic) colon and rectal surgery for colorectal neoplasia, diverticulitis, and other diseases of the colon and rectum;

- Surgical procedure either through standard open or minimal invasive approach (laparoscopic or robotic);

- Patients > 18 years of age;

- Able to provide informed written consent

- Patients capable of completing questionnaires at the time of consent

Exclusion Criteria:

- Documented allergic reaction to morphine, hydromorphone, lidocaine, bupivicaine and/or fentanyl;

- Contra-indication to placement of epidural catheter (spinal stenosis, spinal fusion, elevated INR, anticoagulation, patient refusal, etc) or TAP block (patient refusal);

- Urgent or emergent surgery precluding epidural catheter placement or TAP block;

- Systemic Infection contraindicating epidural catheter placement or TAP block;

- Unwillingness to participate in follow up assessments;

- Prisoners

- Pregnant women

Study Design


Intervention

Procedure:
TAP Block
This is a one time injection of Exparel in the plane between the internal oblique and transversus abdominis muscles
Continuous Epidural Analgesia
Epidural catheter placed prior to the operation in the standard fashion

Locations

Country Name City State
United States Saint Joseph Mercy Hospital Ann Arbor Michigan

Sponsors (1)

Lead Sponsor Collaborator
Saint Joseph Mercy Health System

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Patient use of supplemental narcotic analgesia post-operative day 1 Measured in morphine equivalents Post-operative day 1
Other Patient use of supplemental narcotic analgesia post-operative day 2 Measured in morphine equivalents Post-operative day 2
Other Patient use of supplemental narcotic analgesia post-operative day 3 Measured in morphine equivalents Post-operative day 3
Primary Post-operative pain control day 1 using the numeric pain scale Measured by patient using the numeric pain scale Post-operative day 1
Primary Post-operative pain control day 2 using the numeric pain scale Measured by patient using the numeric pain scale Post-operative day 2
Primary Post-operative pain control day 3 using the numeric pain scale Measured by patient using the numeric pain scale Post-operative day 3
Secondary Overall benefits of analgesia treatment post-operative day 1 Measured by patient completing the Overall Benefits of Analgesia Score survey Post-operative day 1
Secondary Overall benefits of analgesia treatment post-operative day 2 Measured by patient completing the Overall Benefits of Analgesia Score survey Post-operative day 2
Secondary Overall benefits of analgesia treatment post-operative day 3 Measured by patient completing the Overall Benefits of Analgesia Score survey Post-operative day 3
See also
  Status Clinical Trial Phase
Recruiting NCT06380101 - Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) N/A
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT04323722 - Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Active, not recruiting NCT01347697 - Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer N/A
Recruiting NCT04495088 - Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer Phase 3
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Not yet recruiting NCT03520088 - PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS N/A
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1
Recruiting NCT04749381 - The Role of TCM on ERAS of Rectal Cancer Patients Phase 2
Enrolling by invitation NCT05028192 - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Recruiting NCT03283540 - Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
Completed NCT04534309 - Behavioral Weight Loss Program for Cancer Survivors in Maryland N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Recruiting NCT04852653 - A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Terminated NCT02933944 - Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer Phase 1
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A